What is the latest news on MPLT? | Glauxie AI

Q: What is the latest news on MPLT?

8 news articles for MPLT in the past 30 days. Latest: "MapLight's CFO Just Sold 36,000 Shares for $1 Million. Is It a Buy, Sell, or Hold?". 3 SEC Form 8-K filings in the past 90 days.

Q: What happened to MPLT today?

Get a recap of what happened to MPLT stock today — price move, catalysts, and key events.

Q: Why is MPLT going up today?

Find out why MPLT stock is up today with real-time data, news catalysts, and move analysis.

Q: Why is MPLT down today?

Find out why MPLT stock is down today with real-time data, news catalysts, and move analysis.

What is the latest news on MPLT?

🦉

Latest News & Events — MPLT

8 articles in the past 30 days

MapLight Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update
Benzinga-Biotech ·

MapLight Therapeutics to Participate in Upcoming Investor Conferences
Benzinga-Biotech ·

This MapLight Insider Sold 69,000 Shares for $2.1 Million at the End of April
MotleyFool ·

This First Tracks Biotherapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Monday
Benzinga-News ·

MapLight Therapeutics Announces Completion of Enrollment in ZEPHYR Phase 2 Trial and Updates Expected Timing of Topline Results
GlobeNewsWire-FDA ·

MapLight Therapeutics Announces Completion of Enrollment in ZEPHYR Phase 2 Trial and Updates Expected Timing of Topline Results
Benzinga-Biotech ·

Analysts Set Maplight Therapeutics, Inc. (NASDAQ:MPLT) Target Price at $32.67
DefenseWorld ·

Analyst Actions

Firm	Action	Date

SEC Form 8-K Filings (3 in 90 days)

—

MPLT News MPLT Overview

What happened to MPLT today? Why is MPLT going up today? Why is MPLT down today?

Latest News & Events — MPLT

Top Stories

Analyst Actions

SEC Form 8-K Filings (3 in 90 days)

Sign in to InsiderStreet